Literature DB >> 4344064

Circulatory changes following prolactin administration.

E E Bryant, B H Douglas, A D Ashburn.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4344064     DOI: 10.1016/0002-9378(73)90088-4

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


× No keyword cloud information.
  7 in total

1.  Altered renal function in chronically hyperprolactinaemic rats.

Authors:  H O Garland; A G Lewis; C M Milne
Journal:  J Physiol       Date:  1987-12       Impact factor: 5.182

2.  Power spectral analysis of plethysmographic pulse waveform in pregnant women.

Authors:  Yi-Ju Su; Wan-An Lu; Gau-Yang Chen; Margaret Liu; Hsiang-Tai Chao; Cheng-Deng Kuo
Journal:  J Clin Monit Comput       Date:  2011-08-09       Impact factor: 2.502

3.  Maternal and fetal prolactin in pregnancy-induced hypertension.

Authors:  M G Marlettini; A Cassani; A M Morselli-Labate; S Crippa; A Contarini; R Miniero; L Platè; C Orlandi
Journal:  Arch Gynecol Obstet       Date:  1990       Impact factor: 2.344

4.  Renal and vascular activity of prolactin preparations. Contamination of prolactin preparations with ADH and implications on renal and vascular prolactin research.

Authors:  H Vorherr
Journal:  Klin Wochenschr       Date:  1979-02-01

5.  Relationship between serum prolactin concentration, vascular angiotensin sensitivity and arterial blood pressure during third trimester pregnancy.

Authors:  T Oney; O Bellmann; H Kaulhausen
Journal:  Arch Gynecol Obstet       Date:  1988       Impact factor: 2.344

6.  Acute and chronic effects of progesterone and prolactin on renal function in the rat.

Authors:  A O Elkarib; H O Garland; R Green
Journal:  J Physiol       Date:  1983-04       Impact factor: 5.182

7.  Relative Postpartum Retinal Vasoconstriction Detected With Optical Coherence Tomography Angiography.

Authors:  Benjamin R Lin; Fei Lin; Li Su; Marco Nassisi; SriniVas R Sadda; Stephanie L Gaw; Irena Tsui
Journal:  Transl Vis Sci Technol       Date:  2021-02-05       Impact factor: 3.283

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.